Hand Orthosis for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new device called MyHand-SCI, designed to assist individuals with hand function after a spinal cord injury at levels C6-C7. The goal is to evaluate the effectiveness of the device's hardware and software in improving grip and release activities. Individuals who have experienced a spinal cord injury in this area for more than six months and have difficulty with hand and finger movement might find this trial suitable. Participants will use the device in multiple sessions to assess its impact on hand use. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance hand function for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the MyHand-SCI device is safe for individuals with C6-C7 spinal cord injury?
Research has shown that the MyHand-SCI device has been tested with individuals who have C6 spinal cord injuries and has shown promise in improving hand function. An initial study demonstrated that the device helped users increase hand strength and the ability to hold objects without losing control, suggesting good user tolerance. While specific safety details are not provided, the testing phase indicates that the device is still under assessment for safety and effectiveness. Early results are positive, but ongoing testing remains crucial to fully understand any potential risks.12345
Why are researchers excited about this trial?
The MyHand-SCI device is unique because it offers a hands-on approach for people with spinal cord injuries to regain hand function. Unlike traditional therapies that might focus on physical therapy exercises or electrical stimulation, the MyHand-SCI device allows users to actively engage in grasp and release activities with a customized orthotic device. This device stands out because it lets users trial various controls and components, potentially offering more adaptability and precision in restoring hand movement. Researchers are excited about this treatment because it could lead to improved independence and quality of life for individuals living with spinal cord injuries.
What evidence suggests that the MyHand-SCI device is effective for improving hand function in C6-C7 spinal cord injury?
Research has shown that the MyHand-SCI device, which participants in this trial will test, can help people with C6-C7 spinal cord injuries use their hands more effectively. This device provides physical support and uses software to assist with hand movements like grabbing and releasing objects. Early results suggest that users might find it easier to perform everyday tasks. While more data is being gathered, the device aims to help people with these spinal cord injuries become more independent.13456
Who Is on the Research Team?
Joel Stein, MD
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for individuals with C6-C7 spinal cord injury who are at least 6 months post-injury and have significantly reduced hand and finger function. They must be able to consent to the study. People with open wounds, severe upper limb pain, intense spasticity, or fixed contractures that limit arm use cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Device Testing
Subjects will attend 1-20 sessions to trial a variety of the MyHand-SCI device controls and/or components. Participants will practice various grasp and release activities with the device.
Follow-up
Participants are monitored for safety and effectiveness after device testing
What Are the Treatments Tested in This Trial?
Interventions
- MyHand-SCI Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator